• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

商业侧向流动免疫分析与 ELISA 用于 SARS-CoV-2 抗体检测的比较。

Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection.

机构信息

Microbiology Department, Consorcio Hospital General Universitario. Address: Av. Tres Cruces s/n, 46014, Valencia, Spain.

Microbiology Department, Consorcio Hospital General Universitario. Address: Av. Tres Cruces s/n, 46014, Valencia, Spain.

出版信息

J Clin Virol. 2020 Aug;129:104529. doi: 10.1016/j.jcv.2020.104529. Epub 2020 Jun 29.

DOI:10.1016/j.jcv.2020.104529
PMID:32659710
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7323682/
Abstract

BACKGROUND

COVID-19 pandemic has spread worldwide since December 2019. Serological tests for SARS-CoV-2 antibody testing are needed for detection of current or past infections. A wide range of commercial tests is available. However, most of them need to be validated.

STUDY DESIGN

The aim was to compare a commercial IgG and IgA ELISA (Euroimmun) with three lateral flow immunoassays (LFI): Hangzhou Alltest Biotech, Wuhan UNscience Biotechnology and Guangzhou Wondfo Biotech. Specificity was calculated with 62 available serum samples from 2018/19. The study included 152 sera from patients of which 109 were RT-PCR positive. Sensitivities for ELISA anti SARS-CoV-2 IgG and IgA were 81.5 % and 93.1 % and specificities 100 % and 80.6 %, respectively. LFI showed variable performances, overall results being better for Guangzhou Wondfo Biotech.

CONCLUSIONS

Commercial serological tests are useful for detection of antibodies in patients with COVID-19. ELISA presented better results than LFI. The results allowed to incorporate the most sensitive LFI to the daily workflow, combining with ELISA. Careful validation is encouraged before clinical laboratories start using these tests.

摘要

背景

自 2019 年 12 月以来,COVID-19 疫情已在全球范围内蔓延。需要进行 SARS-CoV-2 抗体检测的血清学检测来检测当前或过去的感染。有各种各样的商业检测方法,但大多数都需要验证。

设计

本研究旨在比较一种商业 IgG 和 IgA ELISA(欧蒙)与三种侧向流动免疫测定法(LFI):杭州艾康生物技术、武汉华大因源生物技术和广州万孚生物技术。特异性用 2018/19 年的 62 个血清样本计算。该研究纳入了 152 例患者的血清,其中 109 例 RT-PCR 阳性。ELISA 抗 SARS-CoV-2 IgG 和 IgA 的灵敏度分别为 81.5%和 93.1%,特异性分别为 100%和 80.6%。LFI 表现出不同的性能,整体结果以广州万孚生物技术更好。

结论

商业血清学检测可用于检测 COVID-19 患者的抗体。ELISA 比 LFI 结果更好。这些结果允许将最敏感的 LFI 与 ELISA 结合,纳入日常工作流程。在临床实验室开始使用这些检测方法之前,鼓励进行仔细验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c132/7323682/ad596cf027c5/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c132/7323682/ad596cf027c5/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c132/7323682/ad596cf027c5/gr1_lrg.jpg

相似文献

1
Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection.商业侧向流动免疫分析与 ELISA 用于 SARS-CoV-2 抗体检测的比较。
J Clin Virol. 2020 Aug;129:104529. doi: 10.1016/j.jcv.2020.104529. Epub 2020 Jun 29.
2
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).评估三种免疫测定法(Euroimmun 和 Abbott 的两种自动化免疫测定法以及 NG Biotech 的一种快速侧向流动免疫测定法)用于诊断 COVID-19 的 SARS-CoV-2 血清学检测。
J Clin Virol. 2020 Aug;129:104511. doi: 10.1016/j.jcv.2020.104511. Epub 2020 Jun 15.
3
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.六种 SARS-CoV-2 免疫分析试剂与微量中和试验的比较性能。
J Clin Virol. 2020 Aug;129:104512. doi: 10.1016/j.jcv.2020.104512. Epub 2020 Jun 15.
4
Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies.评价两种自动化和三种快速侧向流动免疫测定法用于检测抗 SARS-CoV-2 抗体。
J Clin Virol. 2020 Jul;128:104413. doi: 10.1016/j.jcv.2020.104413. Epub 2020 May 5.
5
Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.评估严重急性呼吸综合征冠状病毒2(SARS-CoV-2)血清学检测工具的性能及其在2019冠状病毒病(COVID-19)诊断策略中的定位。
Diagn Microbiol Infect Dis. 2020 Dec;98(4):115181. doi: 10.1016/j.diagmicrobio.2020.115181. Epub 2020 Aug 21.
6
Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.四种即时侧向流动免疫分析法,用于诊断 COVID-19 并评估针对 SARS-CoV-2 的抗体反应动态。
J Infect. 2020 Sep;81(3):435-442. doi: 10.1016/j.jinf.2020.06.023. Epub 2020 Jun 15.
7
A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.一种基于细胞的 ELISA 方法,可改善抗 SARS-CoV-2 IgG 的血清学分析。
Viruses. 2020 Nov 8;12(11):1274. doi: 10.3390/v12111274.
8
Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.评估 EUROIMMUN 抗 SARS-CoV-2 ELISA 检测试剂盒用于检测 IgA 和 IgG 抗体。
J Clin Virol. 2020 Aug;129:104468. doi: 10.1016/j.jcv.2020.104468. Epub 2020 May 23.
9
Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG.四种新型商业血清学检测试剂盒用于 SARS-CoV-2 IgG 检测的比较。
J Clin Virol. 2020 Jul;128:104394. doi: 10.1016/j.jcv.2020.104394. Epub 2020 Apr 29.
10
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.Abbott ARCHITECT SARS-CoV-2 IgG 免疫分析与间接免疫荧光法和病毒微量中和试验的比较性能评估。
J Clin Virol. 2020 Aug;129:104539. doi: 10.1016/j.jcv.2020.104539. Epub 2020 Jul 6.

引用本文的文献

1
Plasmonic coffee-ring biosensing for AI-assisted point-of-care diagnostics.用于人工智能辅助即时诊断的表面等离子体激元咖啡环生物传感技术。
Nat Commun. 2025 May 17;16(1):4597. doi: 10.1038/s41467-025-59868-y.
2
Antibodies response in symptomatic and asymptomatic SARS-CoV-2 infected persons in Thailand.泰国有症状和无症状的新冠病毒感染者的抗体反应。
PLoS One. 2025 Feb 11;20(2):e0308850. doi: 10.1371/journal.pone.0308850. eCollection 2025.
3
Integrated Ultrasound-Enrichment and Machine Learning in Colorimetric Lateral Flow Assay for Accurate and Sensitive Clinical Alzheimer's Biomarker Diagnosis.

本文引用的文献

1
Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples.利用冠状病毒病(COVID-19)患者样本评估商业和自动化 SARS-CoV-2 IgG 和 IgA ELISA 检测方法。
Euro Surveill. 2020 May;25(18). doi: 10.2807/1560-7917.ES.2020.25.18.2000603.
2
Estimation of COVID-19 prevalence in Italy, Spain, and France.估算意大利、西班牙和法国的 COVID-19 流行率。
Sci Total Environ. 2020 Aug 10;729:138817. doi: 10.1016/j.scitotenv.2020.138817. Epub 2020 Apr 22.
3
Antibody responses to SARS-CoV-2 in patients with COVID-19.
基于集成超声增强和机器学习的比色侧向流动分析用于准确和灵敏的临床阿尔茨海默病生物标志物诊断。
Adv Sci (Weinh). 2024 Nov;11(42):e2406196. doi: 10.1002/advs.202406196. Epub 2024 Sep 19.
4
Surface Acoustic Wave-Driven Enhancement of Enzyme-Linked Immunosorbent Assays: ELISAW.表面声波驱动增强酶联免疫吸附测定:ELISAW。
Anal Chem. 2024 Jun 11;96(23):9676-9683. doi: 10.1021/acs.analchem.4c01615. Epub 2024 May 30.
5
Rapid and Sensitive Detection of Inactivated SARS-CoV-2 Virus via Fiber-Optic and Electrochemical Impedance Spectroscopy Based Aptasensors.基于光纤和电化学阻抗谱的适体传感器快速灵敏检测失活 SARS-CoV-2 病毒。
Biosensors (Basel). 2024 May 7;14(5):231. doi: 10.3390/bios14050231.
6
Development and evaluation of a Lateral flow immunoassay (LFIA) prototype for the detection of IgG anti-SARS-CoV-2 antibodies.用于检测抗SARS-CoV-2 IgG抗体的侧向流动免疫分析(LFIA)原型的开发与评估
Heliyon. 2024 Apr 18;10(9):e29938. doi: 10.1016/j.heliyon.2024.e29938. eCollection 2024 May 15.
7
Advances in nanobiosensors during the COVID-19 pandemic and future perspectives for the post-COVID era.新冠疫情期间纳米生物传感器的进展及后新冠时代的未来展望。
Nano Converg. 2024 Jan 11;11(1):3. doi: 10.1186/s40580-023-00410-5.
8
A Systematic Review and Meta-Analysis Comparing the Diagnostic Accuracy Tests of COVID-19.一项比较新冠病毒病诊断准确性测试的系统评价和荟萃分析
Diagnostics (Basel). 2023 Apr 26;13(9):1549. doi: 10.3390/diagnostics13091549.
9
Enhancing a SARS-CoV-2 nucleocapsid antigen test sensitivity with cost efficient strategy through a cotton intermembrane insertion.通过棉膜夹层插入的成本效益策略提高 SARS-CoV-2 核衣壳抗原检测的灵敏度。
Sci Rep. 2023 Mar 22;13(1):4690. doi: 10.1038/s41598-023-31641-5.
10
Identify the Virus-like Models for COVID-19 as Bio-Threats: Combining Phage Display, Spectral Detection and Algorithms Analysis.鉴定 COVID-19 的病毒样模型作为生物威胁:结合噬菌体展示、光谱检测和算法分析。
Int J Mol Sci. 2023 Feb 6;24(4):3209. doi: 10.3390/ijms24043209.
新型冠状病毒肺炎(COVID-19)患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
4
Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的免疫球蛋白G和IgM抗体概况
Clin Infect Dis. 2020 Nov 19;71(16):2255-2258. doi: 10.1093/cid/ciaa489.
5
Real-time RT-PCR in COVID-19 detection: issues affecting the results.实时逆转录聚合酶链反应在新冠病毒检测中的应用:影响结果的因素
Expert Rev Mol Diagn. 2020 May;20(5):453-454. doi: 10.1080/14737159.2020.1757437. Epub 2020 Apr 22.
6
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.严重急性呼吸综合征冠状病毒 2 特异性抗体反应在冠状病毒疾病患者中。
Emerg Infect Dis. 2020 Jul;26(7):1478-1488. doi: 10.3201/eid2607.200841. Epub 2020 Jun 21.
7
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.新型冠状病毒病 2019 患者的 SARS-CoV-2 抗体反应。
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. doi: 10.1093/cid/ciaa344.
8
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.SARS-CoV-2 感染后口咽后唾液样本和血清抗体反应中的病毒载量时间特征:一项观察性队列研究。
Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23.
9
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).分析早期体液免疫反应以诊断新型冠状病毒病(COVID-19)。
Clin Infect Dis. 2020 Jul 28;71(15):778-785. doi: 10.1093/cid/ciaa310.
10
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.严重急性呼吸综合征相关冠状病毒:将 2019-nCoV 进行分类并命名为 SARS-CoV-2。
Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.